EyePoint Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release…

Biotechnology
US, Watertown [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of EYPT's Analysis
CIK: 1314102 CUSIP: 30233G209 ISIN: US30233G2093 LEI: - UEI: -
Secondary Listings
EYPT has no secondary listings inside our databases.